ClinConnect ClinConnect Logo
Search / Trial NCT06368544

Effect of Early Gait Training on Knee Cartilage Degeneration After Anterior Cruciate Ligament Reconstruction

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Apr 11, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Anterior Cruciate Ligament Injuries Gait Training Cartilage Biochemical Characteristics Anterior Cruciate Ligament Reconstruction

ClinConnect Summary

This clinical trial is studying how early gait training—essentially, the way people walk—can affect knee cartilage health after surgery to repair a torn anterior cruciate ligament (ACL). The goal is to understand if starting this training soon after surgery can help prevent deterioration of the cartilage in the knee, which is important for maintaining joint health. Researchers believe that by improving how people move, they can reduce the risk of long-term knee problems.

To participate in the study, patients need to meet specific criteria. They should be diagnosed with a first-time ACL tear confirmed by an MRI, be between 18.5 and 23.9 in body mass index (BMI), and have had their injury within the last six months. Participants should also be recovering well enough that their knee shows no major signs of inflammation or pain. This trial is currently looking for patients aged 65 to 74, and all genders are welcome. If someone joins the study, they can expect to receive guidance on early rehabilitation exercises aimed at improving their recovery and protecting their knee health in the long run.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with ACL rupture were diagnosed by MRI;
  • 2. Unilateral ACL rupture for the first time should be performed in our hospital (Department of Sports Medicine, Peking University Third Hospital)The art of reconstruction;
  • 3. Normal BMI range: 18.5-23.9 kg/m2;
  • 4. Within 6 months from the trauma;
  • 5. The affected knee joint has passed the acute stage, no obvious redness, pain,inflammation, and limited joint motion,basically restore joint motion.
  • Exclusion Criteria:
  • 1. BMI\<18.5 kg/m2 or BMI≥24 kg/m2);
  • 2. There is a history of contralateral lower limb musculoskeletal system injury and surgery;
  • 3. ACL injury time \> 6 months;
  • 4. Outerbridge damage rating Ⅲ and Ⅳ;
  • 5. Patients with meniscal tears who are expected to undergo meniscal suture surgery at the time of ACLR surgery;
  • 6. Serious injury to the posterior cruciate ligament, medial collateral ligament, or lateral collateral ligament;
  • 7. There is metabolic syndrome (obesity, dyslipidemia, diabetes, etc.), which will involve articular cartilage Epidemic diseases, serious cardiovascular and cerebrovascular diseases, etc.;
  • 8. Those who do not want to accept this treatment

About Peking University Third Hospital

Peking University Third Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare, innovative research, and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital emphasizes the integration of cutting-edge scientific research with patient-centered care to enhance therapeutic outcomes. With a multidisciplinary approach, the institution fosters collaboration among top-tier medical professionals and researchers, striving to contribute to the global medical community through rigorous clinical studies that address pressing health challenges. Its dedication to ethical standards and regulatory compliance ensures the safety and efficacy of new treatments, ultimately aiming to improve patient care and outcomes on both a national and international scale.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

ren shuang, doctor

Study Chair

Be affiliated with the organization

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported